SALT LAKE CITY, May 20, 2021 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that Melissa Gonzalez has been named president of its Women’s Health business.
SALT LAKE CITY, May 20, 2021 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that Melissa Gonzalez has been named president of its Women’s Health business.
English 
简体中文